CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $74.5B, higher than 95% of all stocks globally
- PositionOperating margin is 43.3%, higher than 95% of its Diagnostics & Research peers (median 9.2%)
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.96%Below 5Y avg (1.17%)
Annual Rate
CNY 1.58Paid annual
Payout Ratio
26.1%Sustainable
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
500.97BCNY74.50B · vs all stocks (USD)
Trailing P/E
22.75xvs Diagnostics & Research peers
Revenue (TTM)
51.52BCNY7.66B · vs all stocks (USD)
Profit Margin
42.26%vs Diagnostics & Research peers
Beta
0.4610xvs all stocks
52-Week Change
74.41%vs all stocks
Market Capitalization
500.97BCNY74.50B · vs all stocks (USD)
Enterprise Value
447.66BCNY66.57B · vs all stocks (USD)
Trailing P/E
22.75xvs Diagnostics & Research peers
Forward P/E
17.67xvs Diagnostics & Research peers
Price to Sales (TTM)
9.72xvs Diagnostics & Research peers
Price to Book (MRQ)
5.86xvs Diagnostics & Research peers
Enterprise to Revenue
8.69xvs Diagnostics & Research peers
Enterprise to EBITDA
17.40xvs Diagnostics & Research peers
Gross Margin
56.56%vs Diagnostics & Research peers
Profit Margin
42.26%vs Diagnostics & Research peers
Operating Margin
43.34%vs Diagnostics & Research peers
Return on Assets (TTM)
13.95%vs Diagnostics & Research peers
Return on Equity (TTM)
28.37%vs Diagnostics & Research peers
Revenue (TTM)
51.52BCNY7.66B · vs all stocks (USD)
Revenue per Share (TTM)
17.71CNYUpdated Aug 21, 2026Quarterly Revenue Growth
32.37%vs Diagnostics & Research peers
Gross Profit (TTM)
27.58BCNY4.10B · vs all stocks (USD)
EBITDA (TTM)
27.79BCNY4.13B · vs all stocks (USD)
Net Income (TTM)
20.34BCNY3.02B · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
47.71%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
19.47BCNY2.90B · vs all stocks (USD)
Levered Free Cash Flow (TTM)
9.64BCNY1.43B · vs all stocks (USD)
Trailing Annual Dividend Rate
1.58CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.96%vs all stocks
5-Year Average Dividend Yield
1.17%vs all stocks
Payout Ratio
26.14%vs Diagnostics & Research peers
Minority Interest (Equity)
535.42MCNYFY2025 · Dec 31, 2025Revenue
45.46BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
23.80BCNYFY2025 · Dec 31, 2025Gross Profit
21.65BCNYFY2025 · Dec 31, 2025Operating Income
17.00BCNY2.53B · vs all stocks (USD)
Pre-tax Income
23.91BCNYFY2025 · Dec 31, 2025Income Tax Expense
4.57BCNYFY2025 · Dec 31, 2025Net Income
19.33BCNYFY2025 · Dec 31, 2025EBIT
24.21BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
28.95BCNYFY2025 · Dec 31, 2025Research & Development
1.12BCNYFY2025 · Dec 31, 2025Selling, General & Administrative
930.63MCNYFY2025 · Dec 31, 2025Other Operating Expenses
534.87MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
938.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
306.49MCNYFY2025 · Dec 31, 2025EPS (Basic)
6.70CNYFY2025 · Dec 31, 2025EPS (Diluted)
6.61CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
2.86BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
2.86BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
19.33BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-182.48MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
16.41BCNYFY2025 · Dec 31, 2025Free Cash Flow
10.94BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
29.46BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
19.33BCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.16BCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-229.62MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.86BCNYFY2025 · Dec 31, 2025Capital Expenditures
-5.46BCNYFY2025 · Dec 31, 2025Net Acquisitions
2.90BCNYFY2025 · Dec 31, 2025Purchase of Investments
-20.87BCNYFY2025 · Dec 31, 2025Sale of Investments
21.49BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.95BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
14.09BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-10.53BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-4.97BCNYFY2025 · Dec 31, 2025Other Financing Charges
2.55BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
1.15BCNYFY2025 · Dec 31, 2025Shares Outstanding
2.98BSharesUpdated Aug 21, 2026Float Shares
2.46BSharesUpdated Aug 21, 2026% Held by Insiders
17.90%vs all stocks
% Held by Institutions
22.02%vs all stocks
Total Cash (MRQ)
48.03BCNY7.14B · vs all stocks (USD)
Total Cash per Share (MRQ)
16.41CNYUpdated Aug 21, 2026Total Debt (MRQ)
15.11BCNY2.25B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1802xvs Diagnostics & Research peers
Current Ratio (MRQ)
2.54xvs Diagnostics & Research peers
Book Value per Share (MRQ)
28.64CNYUpdated Aug 21, 2026Total Assets
103.12BCNY15.34B · vs all stocks (USD)
Total Current Assets
61.68BCNYFY2025 · Dec 31, 2025Total Liabilities
22.87BCNYFY2025 · Dec 31, 2025Total Non-current Assets
41.44BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
3.64BCNYFY2025 · Dec 31, 2025Total Current Liabilities
19.24BCNYFY2025 · Dec 31, 2025Cash
35.10BCNYFY2025 · Dec 31, 2025Cash Equivalents
34.70MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
35.13BCNYFY2025 · Dec 31, 2025Other Short-term Investments
5.81BCNYFY2025 · Dec 31, 2025Accounts Receivable
7.26BCNYFY2025 · Dec 31, 2025Inventory
8.99BCNYFY2025 · Dec 31, 2025Accounts Payable
2.45BCNYFY2025 · Dec 31, 2025Short-term Debt
6.15BCNYFY2025 · Dec 31, 2025Long-term Debt
2.27BCNYFY2025 · Dec 31, 2025Common Stock (Book)
2.98BCNYFY2025 · Dec 31, 2025Retained Earnings
46.15BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
80.25BCNY11.93B · vs all stocks (USD)
Treasury Stock
3.84BCNYFY2025 · Dec 31, 202552-Week Low
87.09CNYUpdated Aug 21, 202652-Week High
173.60CNYUpdated Aug 21, 202652-Week Change
74.41%vs all stocks
Beta
0.4610xvs all stocks
50-Day MA
127.50CNYUpdated Aug 21, 2026200-Day MA
105.31CNYUpdated Aug 21, 2026Avg 10-Day Volume
76.82MSharesUpdated Aug 21, 2026Avg 30-Day Volume
71.08MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
7.38CNYUpdated Aug 21, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Diagnostic
High ROE With Large Non-Operating Gap and Elevated-Margin-With-Deceleration
Return on equity reads high, with a large gap between pretax and operating income.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 43.3%, higher than 95% of its Diagnostics & Research peers (median 9.2%)Significant
Operating margin: 0.43Industry median: 0.09Industry P95: 0.34Peers compared: 68.00
Profit margin is 42.3%, higher than 95% of its Diagnostics & Research peers (median 4.5%)Significant
Profit margin: 0.42Industry median: 0.04Industry P95: 0.21Peers compared: 68.00
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 0.71
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $74.5B, higher than 95% of all stocks globallySignificant
Market cap (USD): 74,499,664,565.433Global P95: 25,614,208,870.135
Levered free cash flow is $1.43B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 1,433,296,465.029Global P95: 1,123,592,359.78
Revenue is $7.66B, above the global median of $520.53MNotable
Revenue (USD): 7,661,393,621.238Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Ecolab Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Naura Technology Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Samsung Electro-Mechanics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Emerson Electric Co.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Medline Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Schlumberger Limited
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
CRH plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Motorola Solutions, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dayou Plus Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
The Sherwin-Williams Company
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Garmin Ltd.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedCash-Flow Ratios Elevated
SJS Enterprises Ltd.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedCash-Flow Ratios Elevated
Yealink Network Technology Co., Ltd.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedCash-Flow Ratios Elevated